US President Donald Trump has said that Volodymyr Zelensky and Vladimir Putin need to "get together" to end the war in ...
Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...
Our fair value estimate for Inghams is AUD 3.70 per share. This implies a fiscal 2024 enterprise value/EBITDA of 4, a P/E ratio of 12, and fully franked dividend yield of 6%. Our DCF valuation assumes ...
Pagaya's AI-driven lending, strong revenue growth, and improving profitability make it a promising fintech, despite funding risks and competition. Read more here.
Donald Trump's push to strike a deal between Russia and Ukraine has rattled Europeans and stoked fears their security will be ...
The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...